BUY MBP AFATINIB AFANAT 40MG 28TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Afatinib is an oral anticancer medicine used mainly to treat a specific type of lung cancer called non-small cell lung cancer, particularly when the cancer has certain genetic changes known as epidermal growth factor receptor or EGFR mutations. Afatinib belongs to a group of medicines called tyrosine kinase inhibitors. These medicines work by blocking signals that tell cancer cells to grow, divide, and spread. By interfering with these signals, afatinib slows down or stops the growth of cancer cells and may shrink tumors.

Afatinib works differently from traditional chemotherapy. Instead of killing rapidly dividing cells in a non-specific way, afatinib targets specific proteins involved in cancer cell signalling. It permanently blocks the activity of EGFR and related receptors, which are often overactive in certain lung cancers. This targeted action helps control cancer growth while reducing damage to normal cells compared with standard chemotherapy.

Afatinib is usually prescribed for patients whose tumors have specific EGFR mutations confirmed through genetic testing. It is most commonly used as a first-line treatment or after other therapies have failed. Because it works at a molecular level, it is not effective in patients whose cancers do not carry these mutations.

Afatinib is taken by mouth once daily, usually on an empty stomach, at least one hour before or two hours after eating. It should be taken at the same time every day to maintain steady drug levels in the body. Tablets should be swallowed whole with water and not crushed or chewed. Consistency is very important for the medication to work properly.

The most common side effects of afatinib involve the skin and digestive system. Many patients experience diarrhoea, which can sometimes be severe if not treated early. Skin reactions such as rash, acne-like eruptions, dryness, itching, or redness are also common. Mouth sores, reduced appetite, nausea, and fatigue may occur as well. These side effects often appear early in treatment and can usually be managed with supportive care or dose adjustments.

Diarrhoea caused by afatinib should be treated promptly, as prolonged diarrhoea can lead to dehydration and electrolyte imbalance. Patients are often advised to drink plenty of fluids and may be prescribed anti-diarrhoeal medicines such as loperamide. Skin reactions should also be reported early, as early treatment helps prevent worsening.

More serious but less common side effects include lung inflammation known as interstitial lung disease, which may cause shortness of breath, cough, or chest pain. This is a medical emergency and requires immediate medical attention. Afatinib can also affect liver function, so regular blood tests are required to monitor liver enzymes during treatment.

Afatinib may interact with other medicines, including certain antibiotics, antifungals, anticonvulsants, and herbal products such as St John?s wort. These interactions can affect how well afatinib works or increase side effects. Patients should always inform their healthcare provider about all medicines, supplements, or herbal products they are using.

Women who are pregnant or planning pregnancy should not take afatinib, as it may harm the unborn baby. Effective contraception is required during treatment and for a period after stopping the medicine. Breastfeeding is also not recommended while taking afatinib.

Patients taking afatinib should attend regular follow-up appointments so that their response to treatment, side effects, and overall health can be closely monitored. Dose adjustments may be necessary to balance effectiveness and tolerability.

Although afatinib does not cure cancer, it can significantly slow disease progression, improve symptoms, and extend survival in patients with EGFR-mutated lung cancer. When taken as prescribed and monitored carefully, afatinib can provide meaningful clinical benefit and improve quality of life for many patients undergoing cancer treatment.